Upgrade to SI Premium - Free Trial

Acadia Pharmaceuticals (ACAD) PT Raised to $36 at Citizens: Remains a Top Pick

August 5, 2026 4:07 AM
Citizens analyst Jason Butler raised the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $36.00 (from $35.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change